"MSD shares drop 5% amid plans for $3bn cost cutting strategy" was originally created and published by Pharmaceutical ...

Turbine, a leading developer of cell simulations with AI, today announced a research collaboration with MSD (the tradename of ...

Employees of the technology transfer centre ANAXAM and researchers from the Paul Scherrer Institute PSI used the unique ...

The U.S. Food and Drug Administration said on Wednesday that it has approved Jazz Pharmaceuticals' drug to treat diffuse ...

MSD is slashing $3bn (€2.59bn) from its annual spending as it braces for off-brand competition to its Irish-manufactured ...

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency's drug program.

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715 (together with its subsidiaries and/or affiliated companies, "Sun Pharma") today announced ...

Drug formulation continues to present challenges for pharmaceutical manufacturers, particularly as the industry responds to growing demand for efficient, flexible, and reproducible production methods.

The biopharmaceutical industry is growing rapidly as a result of significant advancements in biotechnology and drug ...

In pharmaceutical research, understanding complex materials is vital; however, current methods are outdated. Tabletop SEM with Raman and EDS is seen as the future for pharmaceutical research.

In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management.

COPENHAGEN, Denmark, July 14, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 156 of its Phase 3 PaTHway Trial confirming that long-term treatment with ...